IBM Turns 100: Marks Numerous Contributions to Healthcare

IBM HealthcareIBM is marking the 100-year anniversary of its founding on June 16, 1911. Few areas of health and medicine have gone untouched by the technology, research and innovation generated by IBM over the past century.

From the first continuous blood separator which led to treatment for leukemia patients, the first heart lung machine to keep patients alive during surgery, the excimer laser used in LASIK eye surgery, to technologies of the future that will one day allow nano-sized particles to enter the bloodstream and fight drug-resistant infections, IBM touches more points in healthcare than anyone else.

IBM has created hardware and applications specifically designed to improve care, improved diagnostics and treatment of disease, and advanced how medical knowledge is shared. This goes far beyond computers. New areas of Research including breakthroughs in gene sequencing and nanotechnology and even innovations in chip design are improving healthcare around the world.

  • In the 1950s, IBM built the first heart-lung machine to be used successfully on a person during surgery.
  • IBM and the National Cancer Institute collaborated in the 1960s to invent the first continuous blood cell separator, which was used for harvesting white cells (and, later, platelets) to treat leukemia patients.
  • Working with the World Health Organization, IBM precisely mapped outbreaks of smallpox in 1976, enabling WHO to allocate its limited personnel and resources to the most urgent locations. The system later became a global model for demographic tracking.
  • IBM invented the method for using excimer lasers that eventually became photorefractive (LASIK) eye surgery.
  • In the early 1990s IBM and the University of Washington built a prototype of the first medical imaging system.
  • IBM's World Community Grid, released in 2004, uses pervasive networking and crowdsourcing to apply supercomputer levels of processing power to urgent healthcare and societal needs such as fighting AIDs, cancer and dengue fever and malaria.
  • Using IBM's Blue Gene supercomputing simulations, researchers at IBM and the University of Edinburgh are currently collaborating on lab experiments to design drugs aimed at preventing the spread of the HIV virus. Until recently, doctors had to make an educated guess about what mix of drugs would work for patients. By simulating the effect of drug cocktails virtually, IBM is helping patients and breaking new barriers in personalized medicine.
  • IBM is currently working with Roche on a DNA Transistor, a high-tech and low-cost way of reading the human genome sequence. This technology may soon be used to create better patient profiles, tailor-made diagnoses and treatments informed by genetics-driving down the cost of healthcare while drastically improving quality of care and quality of life.

Using principles and technologies from computing, physics, material sciences and chemistry, IBM Research has a track record of successfully transferring technology to create new solutions for healthcare. The company spends more than $6B a year on R&D, much of it on healthcare, and IBM is one of the few technology companies with large teams of physicians and other clinicians on staff to ensure we are addressing healthcare's most pressing needs.

Related news articles:

About IBM
For more information about IBM, visit: http://www.ibm.com.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...